The effects of montelukast on antioxidant enzymes and proinflammatory cytokines on the heart, liver, lungs, and kidneys in a rat model of cecal ligation and puncture-induced sepsis

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1341-1356

  Coskun, Ali Kagan ^a   Yigiter, Murat ^b   Oral, Akgun ^a,b   Odabasoglu, Fehmi ^c   Halici, Zekai ^a,b   Mentes, Oner ^a   Cadirci, Elif ^c   Atalay, Fadime ^c   Suleyman, Halis ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c ATATÜRK UNIVERSITY   (Turkey)

Author keywords

IL 6; Montelukast; Oxidative stress; Polymicrobial sepsis; Rat; TNF

Indexed keywords

GLUTATHIONE; INTERLEUKIN 6; LIPID PEROXIDE; MONTELUKAST; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CECUM; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HEART INJURY; KIDNEY INJURY; LIVER INJURY; MALE; MORTALITY; NONHUMAN; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PUNCTURE; RAT; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE;

ACETATES; ANIMALS; CECUM; CYTOKINES; DISEASE MODELS, ANIMAL; GLUTATHIONE; HEART; KIDNEY; LIPID PEROXIDES; LIVER; LUNG; MULTIPLE ORGAN FAILURE; MYOCARDIUM; PEROXIDASE; PROTECTIVE AGENTS; QUINOLINES; RATS; REACTIVE OXYGEN SPECIES; SEPSIS; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 79960523287     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.122     Document Type: Article

References (45)

1. Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M.R. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310.
2. Terblanche, M., Almog, Y., Rosenson, R.S., Smith, T.S., and Hackam, D.G. (2006) Statins: panacea for sepsis? Lancet Infect. Dis. 6, 242-248.
3. Ozdulger, A., Cinel, I., Koksel, O., Cinel, L., Avlan, D., Unlu, A., Okcu, H., Dikmengil, M., and Oral, U. (2003) The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 19, 366-372.
4. Sugerman, H.J., Bloomfield, G.L., and Saggi, B.W. (1999) Multisystem organ failure secondary to increased intraabdominal pressure. Infection 27, 61-66.
5. Moine, P. and Abraham, E. (2004) Immunomodulation and sepsis: impact of the pathogen. Shock 22, 297-308. (Pubitemid 39468968)
6. Herzum, I. and Renz, H. (2008) Inflammatory markers in SIRS, sepsis and septic shock. Curr. Med. Chem. 15, 581-587.
7. Barrera, G., Landoni, V., Martire-Greco, D., Chiarella, P., Meiss, R., Gomez, S.A., Alves-Rosa, F., Rearte, B., Isturiz, M., Palermo, M.S., and Fernandez, G.C. (2011) A model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis. Infect. Immun. 79, 1280-1288.
8. Koksal, G.M., Sayilgan, C., Aydin, S., Oz, H., and Uzun, H. (2004) Correlation of plasma and tissue oxidative stresses in intra-abdominal sepsis. J. Surg. Res. 122, 180-183.
9. Shah, S.V., Baliga, R., Rajapurkar, M., and Fonseca, V.A. (2007) Oxidants in chronic kidney disease. J. Am. Soc. Nephrol. 18, 16-28.
10. Gutteridge, J.M. and Mitchell, J. (1999) Redox imbalance in the critically ill. Br. Med. Bull. 55, 49-75.
11. Peralta, J.G., Llesuy, S., Evelson, P., Carreras, M.C., Flecha, B.G., and Poderoso, J.J. (1993) Oxidative stress in skeletal muscle during sepsis in rats. Circ. Shock 39, 153-159. (Pubitemid 23057754)
12. Collin, M. and Thiemermann, C. (2003) The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock. Eur. J. Pharmacol. 476, 257-258.
13. Verma, R., Huang, Z., Deutschman, C.S., and Levy, R.J. (2009) Caffeine restores myocardial cytochrome oxidase activity and improves cardiac function during sepsis. Crit. Care Med. 37, 1397-1402.
14. Yang, Q.H., Liu, D.W., Long, Y., Liu, H.Z., Chai, W.Z., and Wang, X.T. (2009) Acute renal failure during sepsis: potential role of cell cycle regulation. J. Infect. 58, 459-464.
15. Albayrak, A., Uyanik, M.H., Odabasoglu, F., Halici, Z., Uyanik, A., Bayir, Y., Albayrak, F., Albayrak, Y., Polat, B., and Suleyman, H. (2009) The effects of diabetes and/or polymicrobial sepsis on the status of antioxidant enzymes and pro-inflammatory cytokines on heart, liver, and lung of ovariectomized rats. J. Surg. Res. [Epub ahead of print]
16. Kollef, M.H. and Schuster, D.P. (1995) The acute respiratory distress syndrome. N. Engl. J. Med. 332, 27-37.
17. Dengiz, G.O., Odabasoglu, F., Halici, Z., Cadirci, E., and Suleyman, H. (2007) Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats. J. Pharmacol. Sci. 105, 94-102.
18. Drazen, J.M., Israel, E., and O'Byrne, P.M. (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N. Engl. J. Med. 340, 197-206.
19. Capra, V., Thompson, M.D., Sala, A., Cole, D.E., Folco, G., and Rovati, G.E. (2007) Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med. Res. Rev. 27, 469-527.
20. Rogers, F.B., Dunn, R., and Barrett, A. (1994) Diethylcarbamazine: a leukotriene inhibitor. Effects on red cell deformability in-vitro and in-vivo survival during endotoxemia. Int. J. Microcirc. Clin. Exp. 14, 22-26.
21. Storms, W., Michele, T.M., Knorr, B., Noonan, G., Shapiro, G., Zhang, J., Shingo, S., and Reiss, T.F. (2001) Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years. Clin. Exp. Allergy 31, 77-87.
22. Sener, G., Sehirli, O., Cetinel, S., Ercan, F., Yuksel, M., Gedik, N., and Yegen, B.C. (2005) Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Prostaglandins Leukot. Essent. Fatty Acids 73, 453-462.
23. Sun, Y., Oberley, L.W., and Li, Y. (1988) A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34, 497-500.
24. Bradley, P.P., Priebat, D.A., Christensen, R.D., and Rothstein, G. (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78, 206-209.
25. Ohkawa, H., Ohishi, N., and Yagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
26. Sedlak, J. and Lindsay, R.H. (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25, 192-205.
27. Fujimura, N., Sumita, S., Aimono, M., Masuda, Y., Shichinohe, Y., Narimatsu, E., and Namiki, A. (2000) Effect of free radical scavengers on diaphragmatic contractility in septic peritonitis. Am. J. Respir. Crit. Care Med. 162, 2159-2165.
28. Damas, P., Ledoux, D., Nys, M., Vrindts, Y., De Groote, D., Franchimont, P., and Lamy, M. (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215, 356-362.
29. Ayala, A., Lomas, J.L., Grutkoski, P.S., and Chung, C.S. (2003) Pathological aspects of apoptosis in severe sepsis and shock? Int. J. Biochem. Cell Biol. 35, 7-15.
30. Thijs, L.G. and Hack, C.E. (1995) Time course of cytokine levels in sepsis. Intensive Care Med. 21(Suppl 2), S258-263.
31. Uyanik, A., Unal, D., Uyanik, M.H., Halici, Z., Odabasoglu, F., Altunkaynak, Z.B., Cadirci, E., Keles, M., Gundogdu, C., Suleyman, H., Bayir, Y., Albayrak, M., and Unal, B. (2010) The effects of polymicrobial sepsis with diabetes mellitus on kidney tissues in ovariectomized rats. Ren. Fail. 32, 592-602.
32. Cadirci, E., Altunkaynak, B.Z., Halici, Z., Odabasoglu, F., Uyanik, M.H., Gundogdu, C., Suleyman, H., Halici, M., Albayrak, M., and Unal, B. (2010) Alpha-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats. Shock 33, 479-484.
33. Granger, J. and Remick, D. (2005) Acute pancreatitis: models, markers, and mediators. Shock 24(Suppl 1), 45-51.
34. Volman, T.J., Hendriks, T., Verhofstad, A.A., Kullberg, B.J., and Goris, R.J. (2002) Improved survival of TNF-deficient mice during the zymosan-induced multiple organ dysfunction syndrome. Shock 17, 468-472.
35. Schafer, C., Tietz, A.B., and Goke, B. (2005) Pathophysiology of acute experimental pancreatitis: lessons from genetically engineered animal models and new molecular approaches. Digestion 71, 162-172. (Pubitemid 40910937)
36. Norman, J. (1998) The role of cytokines in the pathogenesis of acute pancreatitis. Am. J. Surg. 175, 76-83.
37. Wenzel, S.E. (1999) Leukotriene receptor antagonists and related compounds. Can. Respir. J. 6, 189-193.
38. Ogilvie, A.C., Groeneveld, A.B., Straub, J.P., and Thijs, L.G. (1991) Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med. 17, 40-44.
39. Garcia, J.J., Reiter, R.J., Guerrero, J.M., Escames, G., Yu, B.P., Oh, C.S., and Munoz-Hoyos, A. (1997) Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett. 408, 297-300. (Pubitemid 27227019)
40. Guo, R.F. and Ward, P.A. (2007) Role of oxidants in lung injury during sepsis. Antioxid. Redox Signal. 9, 1991-2002.
41. Victor, V.M., Rocha, M., Esplugues, J.V., and De la Fuente, M. (2005) Role of free radicals in sepsis: antioxidant therapy. Curr. Pharm. Des. 11, 3141-3158.
42. Ross, D. (1988) Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection. Pharmacol. Ther. 37, 231-249.
43. Carbonell, L.F., Nadal, J.A., Llanos, M.C., Hernandez, I., Nava, E., and Diaz, J. (2000) Depletion of liver glutathione potentiates the oxidative stress and decreases nitric oxide synthesis in a rat endotoxin shock model. Crit. Care Med. 28, 2002-2006.
44. Ritter, C., Andrades, M., Frota Junior, M.L., Bonatto, F., Pinho, R.A., Polydoro, M., Klamt, F., Pinheiro, C.T., Menna-Barreto, S.S., Moreira, J.C., and Dal-Pizzol, F. (2003) Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med. 29, 1782-1789. (Pubitemid 37373825)
45. Navarro, V.J. and Senior, J.R. (2006) Drug-related hepatotoxicity. N. Engl. J. Med. 354, 731-739.